DPP4 and neoplasm: PDPN, PDGFRβ, and αSMA behave similarly and all decrease over time in both tumour types, while the newest CAF marker, CD26, stands out as the only marker with intriguing opposite dynamics over time when comparing the two different tumours: increasing in the aggressive 4T1 while decreasing in 4T07.